Boehringer Ingelheim canning 1,100 workers as it ditches plant

Tools

After years of FDA chidings and resultant drug shortages, Boehringer Ingelheim is pulling the plug on its Ben Venue contract manufacturing business by the end of the year, planning to lay off 1,100 workers. Article